Truist Financial’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Buy
15,621
+205
+1% +$24.8K ﹤0.01% 1485
2026
Q1
$2.52M Sell
15,416
-317
-2% -$48.7K ﹤0.01% 1186
2025
Q4
$2.74M Sell
15,733
-23,330
-60% -$4.26M ﹤0.01% 1118
2025
Q3
$5.63M Sell
39,063
-7,420
-16% -$909K 0.01% 839
2025
Q2
$4.68M Buy
46,483
+1,409
+3% +$108K 0.01% 889
2025
Q1
$3.44M Buy
45,074
+15,036
+50% +$1.15M 0.01% 978
2024
Q4
$2.07M Buy
30,038
+1,000
+3% +$72K ﹤0.01% 1221
2024
Q3
$2.12M Buy
29,038
+22,872
+371% +$1.69M ﹤0.01% 1207
2024
Q2
$413K Buy
+6,166
New +$239K ﹤0.01% 2089

Other funds holding INSM

Truist Financial's INSM Position: Q2 2026 in Review

Truist Financial increased its Insmed (INSM) stake by 1.3% in Q2 2026, buying an estimated $24.8K and bringing the position to 15,621 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

Truist Financial first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.63M in Q3 2025. 281 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Truist Financial held 15,621 shares of Insmed worth $1.67M as of Q2 2026.
  • Truist Financial bought 205 Insmed shares in Q2 2026, an estimated $24.8K.
  • Insmed made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1485 holding.
  • Truist Financial first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • Truist Financial's Insmed position peaked at $5.63M in Q3 2025.
  • 281 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.